GRI

Vision and strategy

1.1	Statement from the Chairman of the Executive Board or Supervisory Board (CR-Report* p.2/3)
1.2	Description of key impacts, risks and opportunities (CR-Report* p.7, 11, 14, 17-20, 23-26, 32-32, 37-38, 42)

Organizational profile

2.1	Name of the organization
2.2	Primary brands, products, and/or services (CR-Report* p.8-9, 17-20, 23-26, 42, 54-55)
2.3	Operational structure of the organization (CR-Report* p.7-9, 50, 54-55)
2.4	Location of organization’s headquarters (CR-Report* p.8, Imprint)
2.5	Number / name of countries with either major operations (CR-Report* p.7-8, 29, 35, 51)
2.6	Nature of ownership and legal form (CR-Report* p.7, 53, GB 28-29, GB 65-67)
2.7	Markets served  (CR-Report* p.7-8, 51)
2.8	Scale of the reporting organization (CR-Report* p.6-9, 29, 50-52, 57)
2.9	Significant changes during the reporting period regarding size, structure, or ownership  (CR-Report* p.8, 17, 21, 33, 53)
2.10	Awards received in the reporting period  (CR-Report* p.21, 27, 29, 30, 33, 37, 61, 68-69)

Report Parameters

Report profile
3.1	Reporting period: business years 2007 and 2008, partially until June 2009
3.2	Date of most recent previous report: 11/2007
3.3	Reporting cycle: CR-Report every 2 years, Facts and figures yearly
3.4	Contact point for questions regarding the report or its contents Maria Schaad, Tel. (06151) 72-0, E-Mail: corpcom@merck.de
Report scope and boundary
3.5	Process for defining report content (incl. priorities) (CR-Report* „About this Report“)
3.6	Boundary of the report (CR-Report* „About this Report“)
3.7	Specific limitations on the scope or boundary of the report (CR-Report* „About this Report“))
3.8	Basis for reporting on joint ventures, etc (CR-Report* „About this Report“)
3.9	Data measurement techniques and the bases for calculation (CR-Report* p.37, 57, 60, 62, 65)
3.10	Explanation of the effect of any re-statements of information provided in earlier reports (CR-Report* p.50-51, 57, 60, 62-63)
3.11	Significant changes from previous reporting periods in the scope, boundary, or measurement methods applied in the report (CR-Report* p.37, 50, 57, 60, 62, 64)
3.12	GRi content index – Table identifying the location of standard disclosures in the report (CR-Report* p.71)
3.13	External verficiation of this report

Governance, Commitments and Engagement

Governance
4.1	Governance structure of the organization, incl. responsibility for sustainability: Company management Factsheet “Company management and stakeholders” (CR-Report* p.7, 14-15)
4.2	Chairman  Factsheet “Company management and stakeholders” (CR-Report* p.14, GB 68-69)
4.3	Governance structure Company management  Factsheet “Company management and stakeholders” (GB 65-69)
4.4	Mechanisms for shareholders and employees to provide  recommendations or direction to the highest governance body **
4.5	Linkage between compensation for members of senior executives and the organization’s sustainability performance **  Corporate Governance  Factsheet “Company management and stakeholders” (GB 67)
4.6	Processes in place to ensure conflicts of interest are avoided  Factsheet “Company management and stakeholders” (CR-Report* p.13)
4.7	Expertise of the governance bodies with respect to sustainability  Factsheet “Company management and stakeholders” (CR-Report* p.14)
4.8	Mission statement, company values and Code of Conduct (CR-Report* p.1, 11-15)
4.9	Executive / Supervisory Board level for overseeing economic, environmental and social risks and opportunities   Factsheet “Company management and stakeholders” (CR-Report* p.14-15, GB 61-64)
4.10	Processes for evaluating the Exeucutive Board’s own performance Factsheet   Factsheet “Company management and stakeholders” (CR-Report* p.14-15)
Commitment to external initiatives
4.11	Application of the precautionary principle    Sustainability program Factsheets “Pharmaceutical Products” and “Chemical Products” (CR-Report* p.6, 7, 11-15, 19-21, 23, 25, 26, 29, 37, 42, 56, 57-58)
4.12	Initiativen External initiatives that the organization endorses    Factsheet “Company management and stakeholders” (CR-Report* p.13, 18-19, 20, 24, 25, 26, 36, 38, 41-42, 69, 70)
4.13	Principle memberships in industry and business associations  stakeholder engagement   Factsheet “Company management and stakeholders” (CR-Report* p.13, 19, 36)
Stakeholder engagement
4.14	List of stakeholder groups engaged by the organization    Factsheet “Company management and stakeholders” (CR-Report* p.68-69)
4.15	Basis for identification and selection of stakeholders with whom to engage Factsheet “Company management and stakeholders” (CR-Report* p.15, 36, 39)
4.16	Approaches to stakeholder dialogue (frequency/type)   Factsheet “Company management and stakeholders” (CR-Report* p.11, 13, 18, 19, 20, 26, 29-30, 36, 39, 43, 53, 68-69)
4.17	Organization’s response to key topics and concerns that have been raised through stakeholder engagement   Factsheet “Company management and stakeholders” (CR-Report* p.15, 20, 30, 33, 39, 68-69)

Performance indicators

Economic
		Management approach Economic figures (CR-Report* p. 11-15)
	aspect : economic performance
EC1		Direct economic value generated and distributed  Facts & Figures  Economic figures (CR-Report* p.6-7, 50-53, 67)
EC2		Financial implications of climate change  Economic figures (CR-Report* p.37**) (Information against the Carbon Disclosure Project - extern link) http://www.cdproject.net
EC3		Coverage of the organization’s defined benefit plan obligations   Social benefits    Economic figures (CR-Report* p.33, 52-53, 58-62)
EC4		Significant financial assistance received from government (CR-Report* p.18**, 24**, 25**, GB 106)
	aspect: market presence
EC6		Spending on local suppliers (CR-Report* p.51)
EC7		Employment of local staff in senior management positions (CR-Report* p.30-32**, 60**)
	aspect: indirect economic impacts
EC8		Infrastructure investments and services provided primarily for public benefit   Responsibility for the community  Economic figures (CR-Report* p.19, 20, 42-43, 47, 53, 66-67)

Environment

Environmental
	Management approach:    Environment and Safety  EHS Management    Environment (CR-Report* p.35-39, 47, 62)
aspect: materials
EN1	Materials used by weight or volume (CR-Report* p.62**, 64**)
EN2	Percentage of materials used that are recycled input materials   Environment (CR-Report* p.47, 65**)
aspect: energy
EN3	Direct energy consumption by primary energy source  Environment (CR-Report* p.62)
EN4	Indirect energy consumption by primary source   Environment (CR-Report* p.63)
aspect: water
EN8	Total water withdrawal by source  Environment (CR-Report* p.64)
aspect: biodiversity
EN11	Use of land in protected areas  Environment (CR-Report* p.39, 65)
EN12	Impact of activities in protected areas   Environment (CR-Report* p.39, 65)
aspect: emissions, effluent and waste
EN16	Total direct and indirect greenhouse gas emissions  Environment (CR-Report* p.37-38, 47, 63)
EN17	Other relevant indirect greenhouse gas emissions caused by business travel and employee commuting Environment (CR-Report* p.65**)
EN19	Emissions of ozone-depleting substances by weight
EN20	NO, SO, and other significant air emissions by weight  Environment (CR-Report* p.63)
EN21	Total water discharge by quality and destination   Environment (CR-Report* p.64)
EN22	Total weight of waste by type and disposal method   Environment (CR-Report* p.65)
EN23	number and volume of significant spills
aspect: products and services
EN26	Initiatives to mitigate environmental impacts of products and services   Preclinic   Regulatory Support Chemicals Factsheets “Pharmaceutical Products” and “Chemical Products” (CR-Report* p.23-25, 26, 27, 36, 46, 55)
EN27	Percentage of products sold and their packaging materials that are reclaimed by category Merck-Disposal-Service   Chemicals   Environment
aspect: compliance
EN28	Significant fines/ Fines for non-compliance with environmental laws - none

Social

Social
Working environment and working
	Management approach:   Employees   Health and safety   Employees and Human Rights (CR-Report* p.11, 13, 29-33, 46-47, 57-62)
aspect: employment
LA1	Total workforce by employment contract, and region   Employees and Human Rights (CR-Report* p.7, 57-58)
LA2	Total number and rate of employee turnover by age group, gender, and region aspect: labor  management relations Employees and Human Rights (CR-Report* p.61**)
aspect: codetermination
LA4	Percentage of employees covered by collective bargaining agreements Employees and Human Rights (CR-Report* p.58)
LA5	Minimum notice period(s) regarding operational changes  (CR Report* p.32**)
aspect: occupational health and safety
LA7	Injuries, absenteeism, fatalities  Employees and Human Rights (CR-Report* p.47, 58-59)
LA8	Risk control programs in place regarding serious diseases   Employees and Human Rights (CR-Report* p.59)
aspect: training and education
LA10	Average hours of training by employee category   Personnel development  (CR Report* p.11, 13, 32, 36, 46, 61)
aspect: dversity and equal opportunity
LA13	Composition of executive management (e.g. gender/nationality) Equal opportunity (CR Report* p.32**, 46, 60)
LA14	Compensation by gender and employee category  Employees and Human Rights (CR Report* p.60)

Human rights
	Management approach:  Employees and Human Rights (CR-Report* p.13, 46, 66)
aspect: investment and procurement practices
HR1	Investment agreements that include human rights clauses  or that have undergone human rights screening Employees and Human Rights (CR-Report* p.13, 46, 66)
HR2	Percentage of significant suppliers and contractors that have undergone screening on human rights and actions taken  Employees and Human Rights (CR-Report* p.13, 46, 66)
aspect: non-discrimination
HR4	Total number of incidents of discrimination and actions taken Equal opportunity  Employees and Human Rights
aspect: Freedom of association and collective bargaining
HR5	Operations with significant risk  Employees and Human Rights (CR-Report* p.58)
aspect: child labor
HR6	Operations identified as having significant risk and measures taken  Employees and Human Rights (CR-Report* p.13, 51, 58)
aspect: Forced and compulsory labor
HR7	Operations identified as having significant risk and measures taken  Employees and Human Rights (CR-Report* p.13, 51)

Society
	Management approach: Community Economic figures (CR-Report* p.11, 13, 15, 41)
aspect: community
SO1	Mitigation of negative impacts of operations on local communities  Economic figures (CR-Report* p.15, 32-33, 39, 66-67)
aspect: corruption
SO2	Percentage and total number of business units analyzed for risks  Economic figures (CR-Report* p.66)
SO3	Percentage of employees trained in anti-corruption policies and procedures  Economic figures (CR-Report* p.13, 66**)
SO4	Actions taken in response to incidents of corruption: no cases of corruption Economic figures (CR-Report* p.66)
aspect: public policy
SO5	Public policy positions and participation in public policy (CR-Report* p.12-13, 15, 26, 36)
aspect: compliance
SO8	Significant fines / sanctions for violation of laws - none

Product responsibility
	Management approach:  Factsheets “Pharmaceutical Products” and “Chemical Products” (CR-Report* p.11, 17, 23, 26)
aspect: customer health and safety
PR1	Life cycle stages in which health and safety impacts of products and services are assessed for improvement:   Pharmaceutical products  Clinical Trials   Chemical products  Factsheets “Pharmaceutical Products” and “Chemical Products” (CR-Report* p.18-20, 26, 55)
aspect: products and services
PR3	Principles / methods of product information and labeling   Chemical products  REACH  Factsheets “Pharmaceutical Products” and “Chemical Products” (CR-Report* p.19, 20, 26, 46, 55)
aspect: marketing communication
PR6	Programs for adherence to laws and voluntary codes related to marketing   Responsible advertising   Chemical products   Factsheets “Pharmaceutical Products” and “Chemical Products” (CR-Report* p.20)
aspect: compliance
PR9	Monetary fines for violations of laws concerning the provision and use of products and services - none